Characterization of a replication competent human immunodeficiency type 2 proviral clone
CA 2047181 A1 · Owner: Franchini, Genoveffa · Inventors: Wong-Staal, Flossie; Gallo, Robert C.; Franchini, Genoveffa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A complete genomic clone of HIV-2 designated HIV-2SBL/ISY was cloned from DNA of the neoplastic human cell line HUT78 infected with the HIV-2SBL6669 viral isolate. The clone was sequenced and the sequence compared with those of known HIV-2 isolates. The invention is advantageous for it provides an animal model for the study of HIV infection in man.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 22, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 22, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 22, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.